Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00536107 · TERMINATED

Trial details

NCT number: NCT00536107
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2007-10-01
Primary completion: 2009-08-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.